Evaluating the contribution of anti-myeloma immunity for the efficacy of oncolytic reovirus therapy

Mueller, L.M.E., Parrish, C., Migneco, G. et al. (6 more authors) (2017) Evaluating the contribution of anti-myeloma immunity for the efficacy of oncolytic reovirus therapy. In: Clinical Cancer Research. Second AACR Conference on Hematologic Malignancies: Translating Discoveries to Novel Therapies, 06-09 May 2017, Boston, MA. American Association for Cancer Research , p. 18.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: ©2017 American Association for Cancer Research. This is an author produced version of a paper subsequently published in Clinical Cancer Research. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: December 2017
Institution: The University of Sheffield
Depositing User: Symplectic Sheffield
Date Deposited: 30 May 2018 15:30
Last Modified: 19 Dec 2022 13:49
Published Version: https://doi.org/10.1158/1557-3265.HEMMAL17-18
Status: Published
Publisher: American Association for Cancer Research
Refereed: Yes
Identification Number: https://doi.org/10.1158/1557-3265.HEMMAL17-18
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)